期刊文献+

人高致病性禽流感病毒H5N1安徽株HA、M2蛋白双顺反子表达载体的构建及表达研究 被引量:5

Construction of Bicistronic Eukaryotic Expression Vector Containing HA and M2 Genes Derived from High Pathogenic Avian Influenza Virus(HPAI)H5N1(Anhui strain)and Its Efficient Expression in Mammalian Cells
下载PDF
导出
摘要 将我国分离的人H5N1亚型禽流感病毒A/Anhui/1/2005作为研究对象,扩增其HA和M2基因片段并克隆至DNA疫苗表达载体pVRC中,构建成真核表达质粒。为提高HA的表达量,按照人偏爱密码子将HA基因进行优化改造,经全基因合成后插入真核表达载体pVRC,以β-actin蛋白为内参比证明了优化后的HA蛋白表达效果明显提高。将M2基因和优化后的HA基因共同克隆入双顺反子表达载体pIRES中,获得同时表达HA或M2的双顺反子真核表达质粒;通过Western blot和间接免疫荧光检测方法,确认构建的重组质粒在真核细胞中成功地表达了目的蛋白HA和M2。通过上述结果为进一步开展人高致病性禽流感病毒安徽株HA和M2基因的功能与致病性研究及使用表达HA和M2蛋白进行新型人用禽流感双价疫苗研发奠定基础。 HA and M2 genes derived from human highly pathogenic avian influenza H5N1 virus (A/Anhui/ 1/2005) isolated from China, were amplified and cloned into the DNA vaccine expression vector pVRC. In order to improve the expression of hemagglutinin, the human codon usage preference was made and the whole length of HA gene of HSNI(A/Anhui/1/2005) influenza virus was synthesized,named HA/YH/K, and inserted to pVRC vector, the expression of HA/YH/K protein in eukaryotic cells was significantly improved according to internal control of actin protein. Furthermore, the M2 and HA/YH/K genes were cloned into bicistronic eukaryotic expressing vector pIRES to yield the recombinant plasmid pIRES-HA/ YH/K-M2/YS/K, which could expressed HA and M2 protein simultaneously by transfection of one plasmid. Western blot and IFA showed that the recombinant pIRES-HA/YH/K-M2/YS/K plasmid was successfully expressed in several mammalian cells (Hela, MDCK and 293FT). The above results may help to identify the function and pathogenic mechanism of HA, M2 genes derived from HPAI H5N1 (Anhui strain)and pave a way for the development of novel bivalent vaccines against human highly pathogenic avian influenza virus and for preparedness for influenza pandemic.
出处 《病毒学报》 CAS CSCD 北大核心 2008年第6期415-420,共6页 Chinese Journal of Virology
基金 "十一五"国家科技支撑计划项目(2006BAD06A15) 国家重点研究发展计划(973)项目(2005CB523000) 国家自然科学基金重大项目(30599433)
关键词 H5N1 HA M2 密码子优化pIRES HSN1 HA M2 codon optimization pIRES
  • 相关文献

参考文献3

二级参考文献36

共引文献6

同被引文献77

  • 1Gambotto A, Barratt-Boyes S M, de Jong M D, et al. Human infection with highly pathogenic H5N1 influenza virus[J]. Lancet, 2008, 371(9622): 1464-1475.
  • 2Shu Y, Yu H, Li D, Lethal avian influenza A (H5N1) infection in a pregnant woman in Anhui Province, China [J]. N Engl J Med, 2006, 354(13): 1421-1422.
  • 3Subbarao K, Luke C. H5N1 viruses and vaccines[J]. PloS Pathog, 2007, 3(3): e40.
  • 4Laddy D J, Weiner D B. From plasmids to protection: a review of DNA vaccines against infectious diseases[J]. Int Rev Immunol. 2006, 25(3-4): 99-123.
  • 5Zhang L, Nolan E, Kreidschitz S, et al. Enhanced delivery of naked DNA to the skin by non-invasive in vivo eleetropsoation[J].BBA, 2002, 1527: 1-9.
  • 6程小雯,郭元吉.流行性感冒病毒及其实验技术[M].北京:中国三峡出版社,1997:100-136.
  • 7Chen M W, Cheng T J, Huang Y, et al. A consensushemagglutinin-based DNA vaccine that protects mice against divergent HSN1 influenza[J]. Proc Natl Aead Sci USA, 2008, 105(36): 13538-13543.
  • 8Rao S, Kong W P, Wei C J, et al. Multivalent HA DNA vaccination protects against highly pathogenic HSN1 avian influenza infection in chickens and mice[J]. PloS ONE, 2008, 3(6): e2432.
  • 9Temperton NJ, Hosehler K, Major D, et al. A sensitive retroviral pseudotype assay for influenza HSN1-neutralizing antibodies[J]. Influenza Other Respi Viruses, 2007, 1(3): 105-112.
  • 10Ami Patel, Tran K, Gray M, et al. Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses[J]. Vaccine, 2009, 27: 3083-3089.

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部